Quad 7 Capital
  • About
  • News
  • Analysis
  • Money Saving Tips
  • Privacy Policy
  • Try BAD BEAT Investing!

Tags archive: HIMS

Home /Tag:HIMS
News

Hims & Hers surges on cheap compounded versions of Novo Nordisk’s semaglutide

May 20, 2024 0

  Hims & Hers Health (NYSE:HIMS) is offering customers access to compounded versions of Novo Nordisk’s (NVO) semaglutide — the active drug in its weight…

Recent Posts

  • Why Your Next iPhone Might Be More Expensive
  • Starbucks’ Latest Brew: Protein Cold Foam Is Here
  • The Boeing Saga: Is This the End of the Road for Criminal Prosecution?
  • A New Contender: OnePay’s Wireless Plan Takes on Major Carriers
  • A Win for Google, a Windfall for Apple?

Archives

  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • February 2025
  • June 2024
  • May 2024
  • January 2022

Quad 7 Capital's Seeking Alpha Feed

  • UnitedHealth: Nothing Is Over
  • Continue To Own Northwest Bancshares For Juicy Income
  • OP Bancorp: Performing Just Fine
  • First Hawaiian: Rangebound, Mixed Performance
  • Atlantic Union Bankshares: Chugging Along
  • Analysis
  • Money Saving Tips
  • News
2025 Quad 7 Capital. All rights reserved. Created by Macho Themes